A
Andreia Valente
Researcher at University of Lisbon
Publications - 54
Citations - 1439
Andreia Valente is an academic researcher from University of Lisbon. The author has contributed to research in topics: Ruthenium & Chain transfer. The author has an hindex of 20, co-authored 48 publications receiving 1190 citations. Previous affiliations of Andreia Valente include university of lille & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish Model.
Brittany F Karas,Jordan M. Hotz,Jordan M. Hotz,Brian M Gural,Kristin R Terez,Victoria L. DiBona,Leonor Côrte-Real,Andreia Valente,Brian Buckley,Keith R. Cooper +9 more
TL;DR: In this article, the authors evaluated novel metallodrugs (PMC79 and LCR134), and cisplatin, a widely used platinum-based chemotherapeutic.
Patent
Macromolecular transition metal complexes for treatment of cancer and process for their preparation
TL;DR: In this paper, a general formula for macromolecular transition metal complexes, characterized by having the general formula (I), to the process for their preparation, and to bidentate and monodentate macroligands.
Journal ArticleDOI
Synthesis, Characterization and Anticancer Studies of Rh(I), Rh(III), Pd(II) and Pt(II) Complexes Bearing A Dithiooxamide Ligand
Banafshe Askari,Hadi Amiri Rudbari,Andreia Valente,Giuseppe Bruno,Nicola Micale,Naveen Shivalingegowda,Lokanath Neratur Krishnappagowda +6 more
Journal ArticleDOI
Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs
TL;DR: It is demonstrated that ruthenium complexes, especially Ru7, have a high anticancer effect against CRC cells and are promising drugs to be used as a new therapeutical strategy for CRC treatment.
Journal ArticleDOI
Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model
Leonor Côrte-Real,Ana R. Brás,Adhan Pilon,Nuno Mendes,Ana Sofia Ribeiro,Tiago Manuel da Rocha Martins,José Paulo S. Farinha,M. Conceição Oliveira,Fátima Gärtner,M. Helena Garcia,Ana Preto,Andreia Valente +11 more
TL;DR: The effects of the compound on the hallmarks of cancer show that the compound leads to apoptosis, interferes with proliferation by affecting the formation of cell colonies in a dose-dependent manner and disrupts the cell cytoskeleton.